Crosstalk between the innate immune system and selective autophagy in hepatitis B virus infection.


Journal

Autophagy
ISSN: 1554-8635
Titre abrégé: Autophagy
Pays: United States
ID NLM: 101265188

Informations de publication

Date de publication:
08 2022
Historique:
pubmed: 6 4 2022
medline: 4 8 2022
entrez: 5 4 2022
Statut: ppublish

Résumé

Although the involvement of macroautophagy/autophagy in hepatitis B virus (HBV) infection has become clearer recently, whether selective autophagy plays an important role in suppressing HBV remains uncertain. We recently found that LGALS9 (galectin 9) is an interferon (IFN)-inducible protein involved in the suppression of HBV replication. Expression of LGALS9 in HBV-infected cells causes the formation of cytoplasmic puncta that degrade the HBV core protein (HBc) in conjunction with RSAD2/viperin, another IFN-inducible protein. LGALS9 binds to HBc via RSAD2 and promotes the autoubiquitination of RNF13 (ring finger protein 13) to recruit SQSTM1/p62, resulting in the formation of LC3-positive autophagosomes that degrade HBc. Both LGALS9 and RSAD2 are encoded by IFN-stimulated genes that act synergistically to induce HBc proteolysis in HBV-infected hepatocytes in an IFN-dependent manner. These results reveal a crosstalk mechanism between the innate immune system and selective autophagy during viral infection.

Identifiants

pubmed: 35380913
doi: 10.1080/15548627.2022.2059747
pmc: PMC9450967
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

2006-2007

Commentaires et corrections

Type : CommentOn

Références

Nat Commun. 2022 Jan 27;13(1):531
pubmed: 35087074

Auteurs

Kei Miyakawa (K)

Department of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan.

Sundararaj Stanleyraj Jeremiah (SS)

Department of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan.

Michinaga Ogawa (M)

Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.

Mayuko Nishi (M)

Department of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan.

Makoto Ohnishi (M)

Department of Bacteriology I, National Institute of Infectious Diseases, Tokyo, Japan.

Akihide Ryo (A)

Department of Microbiology, Yokohama City University School of Medicine, Kanagawa, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH